EMA: Concept paper on the need of the guideline on clinical investigation of medicinal products for the treatment of gout

At present no Committee for Medicinal Products for Human Use (CHMP) guideline has been developed for the clinical development of medicinal products aiming at prevention and / or treatment of gout and / or hyperuricaemia (e.g. urate lowering therapy (ULT) to treat or prevent acute gout flares). A CHMP guidance is needed to express the current state of scientific knowledge in this guideline.